High Dose Ketamine – In Clinic

High-dose ketamine in clinic is a different animal from the troches you take at home. Same molecule, different dose, different route, and a completely different experience. At-home protocols run sublingual lozenges in the 100 to 400mg range, dosed for a light dissociative effect you can ride out on your couch. In-clinic high-dose ketamine is 0.5 to 1mg/kg IV over 40 minutes for treatment-resistant depression, or higher still for ketamine-assisted psychotherapy where the goal is full ego dissolution. We’re talking about a 70kg patient getting 35 to 70mg IV, which puts most people somewhere they cannot drive home from.

The reason this happens in a clinic rather than your kitchen table isn’t squeamishness. Blood pressure goes up. Heart rate goes up. Some people get nauseous. A small subset get genuinely panicked mid-experience and need somebody trained to talk them down without yanking the IV. None of that is catastrophic with proper screening, but it’s not zero, and it’s why ketamine at this dose lives in a room with a pulse oximeter and somebody who knows ACLS.

What the dose buys you, and why it has to be in a clinic

The IV protocol that has the most evidence behind it is Krystal’s original 0.5mg/kg over 40 minutes for treatment-resistant depression. That’s the dose the original Yale trials used, and it’s still the modal dose at most legitimate ketamine clinics. Some clinicians titrate up to 0.75 or 1mg/kg if a patient doesn’t respond at the standard dose. For ketamine-assisted psychotherapy, where the goal is a deeper non-ordinary state for trauma work, doses run higher: 1 to 1.5mg/kg IM, sometimes more.

IM versus IV matters. IV gives you a tight, controllable infusion you can stop if something goes sideways. IM is one injection and you’re committed to the full duration, roughly 45 to 60 minutes of peak. Most depression clinics run IV. Most KAP clinics run IM. Both work. The choice is mostly about what the clinician was trained on and what the room is set up to handle.

The infrastructure isn’t optional. You need a recliner that fully reclines, a quiet room, a blood pressure cuff that cycles every 5 minutes, continuous pulse ox, and somebody in the room or right outside who can manage an airway if something rare goes wrong. Most clinics doing this well have at least one staff member with anesthesia or ER training. The ones that don’t are cutting a corner I wouldn’t cut.

BP is the one to watch. Ketamine reliably bumps systolic pressure 20 to 30 points and diastolic 10 to 15 during the infusion. In a healthy 35-year-old that’s a non-event. In a 62-year-old with poorly controlled hypertension it’s the reason we screen before we dose. People with unstable cardiac disease, recent stroke, or uncontrolled hypertension don’t get ketamine at these doses. People with active psychosis or a strong family history of schizophrenia don’t either.

The experience at 0.5 to 1mg/kg, minute by minute

This is where in-clinic ketamine diverges hard from the at-home version. At 100 to 200mg sublingual, most people get a mild floaty feeling, some time distortion, mood elevation. They can still talk to you. They remember most of it.

At 0.5mg/kg IV, somewhere around minute 8 to 12, the room stops being the room. Visual field goes geometric or tunneled. The sense of having a body recedes. People often describe being “above” themselves, or being part of a pattern, or the dissolution of the boundary between self and everything else. Some people cry. Some people laugh. Some people lie completely still and only later say it was one of the most significant experiences of their life. Some people don’t enjoy it at all and still get the antidepressant effect a few days later.

At 1mg/kg IV or 1.5mg/kg IM, you’re in K-hole territory. Ego dissolution, not metaphorically. The person is not interacting. They’re somewhere else entirely for about 30 to 40 minutes. This is the dose range used for KAP with trauma where the therapeutic theory is that the patient needs to fully step outside their default self to access material that the default self has been guarding.

The session itself isn’t the treatment. What happens in the 72 hours after is.

The reason I say that. Plenty of people have a wild, beautiful, profound in-session experience and feel basically the same a week later. Plenty of people have a session they’d describe as “weird, kind of unpleasant, I don’t get the hype” and wake up the next morning noticing their depression has lifted in a way nothing else has touched in years. The dissociation is a side effect of the dose, not the mechanism that lifts the depression. People conflate the two constantly.

The six-infusion induction, and what comes after

The standard protocol for TRD is six IV infusions over two to three weeks, usually twice a week. The reason for six and not three or ten is that the original trials were structured that way and the response curve flattens around session four to six. People who are going to respond usually show it by infusion three or four. If nothing’s moved by six, more of the same probably won’t either.

I had a woman come in last spring, mid-50s, fifteen-year history of depression, had been through four SSRIs, an SNRI, lithium augmentation, two rounds of TMS. Standard TRD picture. She did the six-infusion induction. Around session three she texted her daughter that she’d been laughing at something on the radio, and the daughter cried because she hadn’t heard her mom laugh like that in a decade. That’s the kind of response that makes ketamine worth the trouble when it works. It doesn’t always work. But when it does it’s fast in a way nothing else in psychiatry is.

Maintenance is the part nobody talks about enough up front. The induction gets the press. The maintenance is what determines whether you’re functionally well a year later. Most responders need single booster infusions every 2 to 6 weeks indefinitely, or they slide back. A subset can stretch the interval out to months. A small subset get a durable remission off a single induction series. I tell people to plan for ongoing maintenance and be pleasantly surprised if they don’t need it.

Who needs in-clinic versus at-home

At-home low-dose troches make sense if you’re functional, your depression is moderate, you’re working with a prescriber who actually checks in on you, and you’ve got the discipline to use them as prescribed rather than as a recreational supply. They’re cheaper, more convenient, and the lower dose means lower risk. For a lot of patients that’s the right rung.

In-clinic high-dose makes sense if you’re severely depressed, acutely suicidal and need something that works in days rather than weeks, you have treatment-resistant depression that hasn’t moved on multiple medication trials, you have PTSD that you want to work on with a KAP-trained therapist, or you tried at-home and got nothing. The clinical setting lets us push the dose to where the evidence is strongest, with the monitoring to make that safe.

One last thing. Cost is real and insurance is patchy. A six-infusion induction usually runs four to six thousand dollars cash, and maintenance runs four to six hundred per session. Spravato (the FDA-approved esketamine nasal spray) is covered by more plans and worth asking about if cost is the barrier. Whoever you go to should give you a real number before you commit.

Before patients walk into the room, I tell them the same thing every time. We’re aiming for them to be measurably less depressed in three weeks. The dissociation, the geometric visuals, the floating-above-the-body sensation, all of it is just what the molecule does at this dose. Some people find it beautiful. Some people find it tedious. Both groups respond to the antidepressant effect at roughly the same rate. People walk out of session one asking whether they did it right, and the honest answer is that nobody knows whether you did it right until we check your PHQ-9 at session four and see whether the number has moved.